This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Neurodevelopmental Disorders
From Proteopedia
| Line 1: | Line 1: | ||
| - | [[Image:|350px|right|thumb| | + | [[Image:Autismbrain.jpg|350px|right|thumb|Description of an Autistic Brain]] |
| - | [[Neurodevelopmental Disorders]] are | + | [[Neurodevelopmental Disorders]] are various disorders which impair growth and development of the brain and/or central nervous system, often resulting in neurological dysfunction. |
| - | + | ||
Articles in Proteopedia concerning [[Neurodevelopmental Disorders]] include:<br/> | Articles in Proteopedia concerning [[Neurodevelopmental Disorders]] include:<br/> | ||
Revision as of 19:52, 2 May 2011
Neurodevelopmental Disorders are various disorders which impair growth and development of the brain and/or central nervous system, often resulting in neurological dysfunction.
Articles in Proteopedia concerning Neurodevelopmental Disorders include:
- Beta-2 Adrenergic Receptor - Involved in Autism
- Ephrin Type-A Receptor - Involved in Tuberous Sclerosis
- FOXP2 - Involved in Speach Disorders
- Ionotropic Glutamate Receptor - Involved in Autism Spectrum Disorders
- Methyl CpG Binding Protein 2 - Involved in Rett Syndrome
- Neuroligin & Neurexin - Involved in Autism
- Potassium Channels
- Serotonin Transporter - Involved in OCD and Autism
- Shank Family Proteins - Involved in 22q13 Deletion Syndrome
To view Neurodevelopmental Disorders related proteins which are Structure Index entries see:
To view automatically seeded indices concerning Neurodevelopmental Disorders See:
To View FDA Approved Treatments for Neurodevelopmental Disorders See: Treatments
To view other Proteopedia pages about diseases & drug targets, See: Pharmaceutical Drug Targets
